Internal cell-penetrating peptide-mediated internalization enables a chimeric lysin to target intracellular pathogens

Int J Pharm. 2021 Apr 15:599:120449. doi: 10.1016/j.ijpharm.2021.120449. Epub 2021 Mar 9.

Abstract

Intracellular pathogens pose serious challenges to the public health worldwide. Lysin, peptidoglycan hydrolase from phage, is promising alternative to conventional antibiotics because of its high bactericidal activity and low risk of resistance. However, most proteinaceous lysins cannot penetrate the mammalian cell membrane because of size exclusion. Previously, we reported a broad-spectrum chimeric lysin, ClyR, with a cysteine, histidine-dependent amidohydrolase/peptidase catalytic domain from PlyC lysin and an SH-3b cell-wall binding domain from PlySs2 lysin. Herein, we further report that a novel internal cell-penetrating peptide (CPP) is predicted in the junction region of the two constitutive domains of ClyR, mediated by which ClyR can be internalized by epithelial cells through caveolin-dependent endocytosis to target intracellular pathogens. Residues K153, P154, R169, and R188 of the internal CPP were found to be essential for ClyR-mediated internalization and intracellular killing. RNA-seq analysis further showed that there are minor differences in transcript and metabolic profiles from epithelial cells exposed to 100 μg/ml ClyR for 24 h. Taken together, our findings demonstrate a novel mechanism of internalization by ClyR, providing new insights into the rational designing of the next-generation lysins to target both extracellular and intracellular pathogens.

Keywords: Bacteriophage lysin; Cell-penetrating peptide; Chimeric lysin; Intracellular pathogen; Lysin therapy.

MeSH terms

  • Animals
  • Anti-Bacterial Agents
  • Bacteriophages*
  • Cell-Penetrating Peptides*
  • N-Acetylmuramoyl-L-alanine Amidase
  • Peptide Hydrolases

Substances

  • Anti-Bacterial Agents
  • Cell-Penetrating Peptides
  • Peptide Hydrolases
  • N-Acetylmuramoyl-L-alanine Amidase